Frankfurt - Delayed Quote EUR
Sol-Gel Technologies Ltd. (4SG.F)
0.5450
-0.0450
(-7.63%)
As of 8:02:51 AM GMT+2. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
45,287
46,628
69,189
59,161
Total Liabilities Net Minority Interest
6,643
4,415
13,595
8,312
Total Equity Gross Minority Interest
38,644
42,213
55,594
50,849
Total Capitalization
38,644
42,213
55,594
50,849
Common Stock Equity
38,644
42,213
55,594
50,849
Capital Lease Obligations
1,653
772
1,591
1,972
Net Tangible Assets
38,644
42,213
55,594
50,849
Working Capital
36,645
39,726
45,415
47,437
Invested Capital
38,644
42,213
55,594
50,849
Tangible Book Value
38,644
42,213
55,594
50,849
Total Debt
1,653
772
1,591
1,972
Share Issued
27,857.6200
23,129.4690
23,126.8040
23,000.7820
Ordinary Shares Number
27,857.6200
23,129.4690
23,126.8040
23,000.7820
12/31/2020 - 7/16/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
CYCC Cyclacel Pharmaceuticals, Inc.
0.2302
+2.04%
GHRS GH Research PLC
9.50
+0.96%
FULC Fulcrum Therapeutics, Inc.
3.5900
-1.64%
CLSD Clearside Biomedical, Inc.
0.7955
-0.56%
ATAI Atai Life Sciences N.V.
1.5200
+3.40%
TPST Tempest Therapeutics, Inc.
7.89
+4.92%
CYBN Cybin Inc.
6.92
-1.84%
MNMD Mind Medicine (MindMed) Inc.
6.11
+5.34%
BEAM Beam Therapeutics Inc.
19.87
+3.87%
NTLA Intellia Therapeutics, Inc.
8.09
-2.65%